Occult Vasoplegia in Normotensive Sepsis: Early Prediction With Diastolic Index and Lactate
DIAL-SEPSIS
Initial Diastolic Shock Index and Lactate as Predictors of Occult Vasoplegia in Normotensive Sepsis.
1 other identifier
observational
526
1 country
1
Brief Summary
The goal of this observational study is to learn if the Diastolic Shock Index (DSI) and initial lactate can predict occult vasoplegia in adults with normotensive sepsis. Normotensive sepsis occurs in patients who have an apparently normal mean arterial pressure but may have impaired vascular tone. The main questions it aims to answer are:
- Can an elevated DSI at admission predict the initiation of vasopressors (norepinephrine) within the first 6 hours of intensive care unit stay?
- How does the combination of initial DSI and lactate perform compared to each marker alone in predicting hemodynamic deterioration? Researchers will compare patients with an elevated DSI to those with a normal DSI to see if this index identifies those who will progress to circulatory shock.Since this is a retrospective cohort study using existing medical records, participants will not be asked to perform any tasks. Researchers will analyze anonymized data, such as heart rate, blood pressure, and lactate levels already recorded in the institutional database.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2024
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2026
CompletedFirst Submitted
Initial submission to the registry
June 15, 2026
CompletedFirst Posted
Study publicly available on registry
June 18, 2026
CompletedJune 18, 2026
June 1, 2026
2.2 years
June 15, 2026
June 15, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Initiation of norepinephrine (vasopressor).
Predictive accuracy, measured by the Area Under the ROC Curve (AUC-ROC), of the initial Diastolic Shock Index (DSI), initial Lactate, and their combination to predict the requirement for norepinephrine. A cutoff point will be defined using the Youden index.
Within the first 6 hours of ICU admission.
Study Arms (2)
Elevated Diastolic Shock Index (DSI)
Adult patients (\>=18 years) admitted to the ICU with a diagnosis of sepsis (Sepsis-3 criteria) who are normotensive upon arrival (MAP \>= 65 mmHg) and not yet receiving vasopressor support, but who present with a Diastolic Shock Index above the optimal cutoff point determined during analysis.
Normal Diastolic Shock Index (DSI)
Adult patients (\>=18 years) admitted to the ICU with a diagnosis of sepsis (Sepsis-3 criteria) who are normotensive upon arrival (MAP \>= 65 mmHg) and not receiving vasopressor support, with a Diastolic Shock Index and lactate levels within normal ranges.
Eligibility Criteria
The study population consists of adult patients admitted to the Intensive Care Unit (ICU) of Hospital H+ Querétaro. The cohort includes individuals with a diagnosis of sepsis (Sepsis-3) who maintain a mean arterial pressure (MAP) \>=65 mmHg without the need for vasopressors during their initial hour of admission. These patients are identified from an existing institutional database covering the period between January 1, 2024, and May 31, 2025. The population represents a specific group of critically ill patients who, despite appearing hemodynamically stable (normotensive), are at risk of rapid progression to overt circulatory collapse and vasoplegia.
You may qualify if:
- Patients over 18 years of age.
- Diagnosis of sepsis upon admission according to Sepsis-3 criteria (suspected or confirmed infection plus an increase in SOFA score \>2).
- Mean Arterial Pressure (MAP) during the first hour \>=65 mmHg.
- No vasopressor infusion at the time of initial assessment (Time 0)
You may not qualify if:
- Patients who died within the first 24 hours of admission.
- Patients transferred out of the unit within the first 24 hours
- Patients who were already receiving vasopressor support in the pre-hospital setting or the emergency department before ICU admission.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital H+
Querétaro City, Querétaro, 7600, Mexico
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Amy Sevilla
Study Record Dates
First Submitted
June 15, 2026
First Posted
June 18, 2026
Study Start
January 1, 2024
Primary Completion
April 1, 2026
Study Completion
April 1, 2026
Last Updated
June 18, 2026
Record last verified: 2026-06